Biobran MGN-3 was first developed in Japan in 1992 by Hiroaki Maeda, Director of Research and Development of Daiwa Pharmaceutical Co., Ltd, in Tokyo. Maeda's area of interest is in finding natural phytonutrient solutions for both human health and agriculture, and in the late 1980s, he turned his attention to polysaccharides, which have been known to have been known to strengthen immune response, and developed the immune system supplement, AHCC®. After moving to Daiwa Pharmaceutical, headed by Yasuo Ninomiya, Maeda developed a new complex of short chain polysaccharides (primarily arabinoxylan and other hemicelluloses glyconutrients) which he gave the generic name MGN-3 after the initials of its developers — M-Maeda, G-Ghoneum, N-Ninomiya and "3" because it was a third generation product. (Mamdooh Ghoneum, Professor of Immunology at Drew University of Medicine and Science in Los Angeles, did much of the immunological research with the product.) Daiwa subsequently marketed this MGN-3 complex under the brand names Biobran.
Arabinoxylan compound (1000mg), Microcrystaline Cellulose (bulking agent), Dextrin (stabiliser), Corn Starch (stabiliser), Tricalcium Phosphate (anti-caking agent).
These sachets contain BioBran MGN-3 in powder form which is dissolved in water. As powder it is better for those needing larger quantities of the supplement; each sachet contains 1g (1000mg).
The recommended dosage for those needing optimum immune system support is 3 grams a day for 8 weeks followed by 1g a day.